CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Germany

15 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Juedisches Krankenhaus Berlin Stiftung Des Buergerlichen Rechts, Berlin · Katholisches Klinikum Bochum gGmbH, Bochum · Universitaetsmedizin Goettingen, Goettingen · Martha-Maria Krankenhaus Halle-Doelau gGmbH, Halle (saale) · Medizinische Hochschule Hannover, Hanover · Universitaetsklinikum Leipzig Aor, Leipzig · Medizinische Versorgungszentren St. Josefs-Krankenhaus Potsdam GmbH, Potsdam · Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V., Ulm
Registry updated 2026-11-03
NCT06920004
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Trial Treatment · Phase 3 · argenx
Charite Universitaetsmedizin Berlin KöR, Berlin · Medical Center- University of Freiburg, Freiburg im Breisgau · Universitaetsklinikum Schleswig-Holstein AöR, Kiel
Registry updated 2026-11-03
NCT07264426
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Research · argenx
Jüdisches Krankenhaus Berlin, Berlin · Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Bochum · UK-RUB - Katholisches Klinikum Bochum - St. Josef Hospital, Bochum · Universitätsklinikum Köln, Cologne · Universitätsklinikum Düsseldorf, Düsseldorf · Universitätsklinikum Frankfurt, Frankfurt · UKGM - Universitätsklinikum Gießen und Marburg GmbH, Giessen · Universitätsmedizin Göttingen, Göttingen · Universitätsklinikum Hamburg-Eppendorf, Hamburg · Neurologie Neuer Wall - Dr.Bredow & Partner, Hamburg · Medizinische Hochschule Hannover, Hanover · Universitätsklinikum des Saarlandes, Homburg · Universitätsklinikum Magdeburg A.ö.R., Magdeburg · Universitätsklinikum Mannheim, Mannheim · Universitätsklinikum Gießen und Marburg GmbH Standort Marburg, Marburg · Mühlenkreiskliniken, Johannes Wesling Klinikum Minden, Minden · Friedrich-Baur-Institute München, München · Alexianer St. Josef Potsdam GmbH, Potsdam · Immanuel Klinik Rüdersdorf, Rüdersdorf · Diakonie-Klinikum Schwäbisch Hall gGmbH, Schwäbisch Hall · Universitätsklinikum Tübingen, Tübingen · Universitätsklinikum Ulm, Ulm
Registry updated 2026-11-03
NCT06858579
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Clinical Study Site, Aachen · Cinical Study Site, Greifswald · Cinical Study Site, München · Clinical Study Site, Rüdersdorf · Clinical Study Site, Sande
Registry updated 2026-10-28
NCT06859099
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Trial Treatment · Phase 3 · Sanofi
Investigational Site Number : 2760002, Göttingen · Investigational Site Number : 2760003, Münster · Investigational Site Number : 2760004, Tübingen
Registry updated 2026-10-27
NCT07882797
Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy
Research · Heinrich-Heine University, Duesseldorf
University Hospital Düsseldorf, Düsseldorf
Registry updated 2026-10-27
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Sanofi
Charite Universitaetsmedizin Berlin KöR, Berlin · Katholisches Klinikum Bochum gGmbH, Bochum · Gesundheit Nord gGmbH Klinikverbund Bremen, Bremen · Universitaetsklinikum Essen (AoR), Essen · Universitaetsmedizin Goettingen, Goettingen · Medizinische Hochschule Hannover, Hanover · Universitaet Des Saarlandes, Homburg · Universitaet Muenster, Muenster · DIAK Klinikum Landkreis Schwaebisch Hall gGmbH, Schwaebisch Hall
Registry updated 2026-10-19
NCT07032662
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2 · Immunovant Sciences GmbH
Katholisches Klinikum Bochum gGmbH, Bochum · Universitaetsklinikum Leipzig Aor, Leipzig · Universitaetsklinikum Ulm AoR, Ulm · Klinikum Wuerzburg Mitte gGmbH, Wuerzburg
Registry updated 2026-09-30
2024-517529-26-00
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics Inc.
Universitaetsklinikum Aachen AöR, Aachen · Universitaetsmedizin Greifswald KöR, Greifswald · Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), Munich · Krankenhaus und Poliklinik Ruedersdorf GmbH, Ruedersdorf · Friesland Kliniken gGmbH, Sande · Universitaetsklinikum Ulm AoR, Ulm
Registry updated 2026-08-28
NCT07273903
Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
Research · Heinrich-Heine University, Duesseldorf
University Hospital Düsseldorf, Düsseldorf · University Hospital Munster, Münster
Registry updated 2026-06-10
NCT04881682
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2 · University of Ulm
Department of Neurology, University of Ulm, Ulm
Registry updated 2026-05-01
NCT06299748
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Research · argenx
Klinikum der Ruhr-Universität Bochum St. Josef Hospital Neurologische Interdisziplinäre Infusionsambulanz + MS Studienambulanz (Haus E Ebene1), Bochum
Registry updated 2026-02-17
NCT07154524
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Research · University of Ulm
University of Ulm, Ulm
Registry updated 2025-09-11
NCT06605612
Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Research · LMU Klinikum
Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München, München
Registry updated 2025-09-10
NCT07072676
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
Trial Treatment · LMU Klinikum
Medical Park, Bad Feilnbach, Reithofpark, Bad Feilnbach
Registry updated 2025-07-18

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error